This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: The Innovative Contributions of Cindy M Pudiak
Introduction
Cindy M Pudiak is a notable inventor based in Binghamton, NY (US). She has made significant contributions to the field of pharmacology, particularly through her work on peptide antagonists. Her innovative approach has led to advancements in understanding and targeting specific receptors in the body.
Latest Patents
Cindy holds a patent for a chimeric peptide antagonist for GPCR135 or GPCR142. The patent describes the chimeric polypeptide R3(Bβ23-27)R/I5, which is recognized as a high-affinity antagonist for GPCR135 and GPCR142 over LGR7. This invention showcases her expertise in developing targeted therapeutic agents.
Career Highlights
Cindy is currently employed at Janssen Pharmaceutica NV, where she continues to push the boundaries of pharmaceutical research. Her work has been instrumental in advancing the understanding of G protein-coupled receptors, which play a crucial role in various physiological processes.
Collaborations
Cindy has collaborated with esteemed colleagues, including Chester Kuei and Changlu Liu. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Cindy M Pudiak's contributions to the field of pharmacology through her innovative patents and collaborative efforts highlight her as a significant figure in the realm of scientific research. Her work continues to impact the development of new therapeutic strategies.